a developer of proprietary technologies for the detection of cancer
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with ILMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then ILMN could also see price increases.
Ticker / NAME | Correlation To EXAS | 1D Price Change % | ||
---|---|---|---|---|
EXAS | 100% | +0.39% | ||
ILMN - EXAS | 34% Loosely correlated | -2.69% | ||
XRAY - EXAS | 33% Poorly correlated | +3.00% | ||
FNA - EXAS | 32% Poorly correlated | -5.83% | ||
ATEC - EXAS | 31% Poorly correlated | -4.38% | ||
TMO - EXAS | 29% Poorly correlated | -1.64% | ||
More |
Ticker / NAME | Correlation To EXAS | 1D Price Change % |
---|---|---|
EXAS | 100% | +0.39% |
detection theme (4 stocks) | 79% Closely correlated | -1.19% |
fighting cancer theme (12 stocks) | 38% Loosely correlated | -2.34% |
cancer theme (82 stocks) | 29% Poorly correlated | -2.35% |
biotechnology theme (238 stocks) | 20% Poorly correlated | -1.76% |
Medical Specialties theme (427 stocks) | 20% Poorly correlated | -1.35% |
More |